Dr. Achim Plum, Special Advisor to Ares Genetics since January 2021, was Founding Managing Director of Ares Genetics from 2017 - 2020. Achim has more than 20 years of management experience in the diagnostics industry with a focus on innovative molecular diagnostics, biomarker development, and personalized medicine. During his term as Managing Director he represented Ares Genetics on the Curetis Executive Board where he held the position of a CBO. Achim joined the Curetis Group in 2015 from a Senior Management position at Siemens Healthcare where he was responsible for Diagnostic and BioScience Technology & Innovation. Prior to Siemens, Achim worked for eight years for the cancer MDx company Epigenomics, lastly as SVP Business & Strategy, that developed commercializes the first FDA-cleared liquid biopsy colorectal cancer screening test. Achim studied Genetics, Cell Biology and Biochemistry in Bonn, Germany, and Norwich UK. He obtained his Ph.D. in Molecular Genetics from the University of Bonn in 1999 and won numerous prizes and scholarships during his academic career.